info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Appendicitis Companies

Appendicitis is a medical condition that involves inflammation of the appendix and typically requires surgical intervention. Companies associated with appendicitis may provide medical devices, diagnostic tools, surgical equipment, or support services for healthcare providers.

Appendicitis Key CompaniesDisclaimer: List of key companies in no particular orderLatest Appendicitis Companies Update



  • August 2023: According to new research, most persons with appendicitis who are given antibiotics instead of having their appendix removed perform well in the long run. The study discovered that among people who were originally treated merely with antibiotics rather than surgery, less than half experienced another incident or required appendix-related surgery years later. The most recent study focused on mild cases, which represent the majority of appendicitis patients who may not require surgical intervention and may potentially resolve spontaneously, avoiding unnecessary surgery and resulting in significant health care cost and hospital resource savings. The major takeaway here is that these long-term findings support the current solid evidence that surgery is not required for all patients with uncomplicated acute appendicitis, and that antibiotic therapy is viable and safe in the long run.



  • A randomized study comparing antibiotics versus appendectomy in the treatment of appendicitis. In 25 U.S. facilities, they conducted a pragmatic, nonblinded, noninferiority, randomized study comparing antibiotic therapy (10-day course) with appendectomy in patients with appendicitis.  Secondary outcomes in the antibiotics group were appendectomy and complications through 90 days; analyses were prespecified in subgroups determined by the presence or absence of an appendicolith. On the basis of the findings of a common health-status assessment, antibiotics were noninferior to appendectomy for the treatment of appendicitis. By 90 days, roughly three out of every ten people in the antibiotics group had undergone appendectomy. Participants who had an appendicolith had a greater risk of appendectomy and complications than those who did not have an appendicolith.


List of Appendicitis Key companies in the market

  • Johnson & Johnson Services Inc (US)

  • Pfizer Inc (US)

  • Lupin (India)

  • Siemens (Germany)

  • Koninklijke Philips NV (Netherlands)

  • Becton, Dickinson and Company (US)

  • Braun Melsungen AG (Germany)

  • Cook (US)

  • Medtronic (Ireland)

  • Teva Pharmaceutical Industries Ltd (Israel).

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.